Nanjing Hicin Pharmaceutical Co Ltd (300584) — Strategic Asset Allocation Index
Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Strategic Asset Allocation Index of 58.7% as of June 2023. Strategic assets (PP&E of CN¥569.89 Million plus long-term investments of CN¥-) total CN¥569.89 Million, measured against net assets of CN¥970.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Nanjing Hicin Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Nanjing Hicin Pharmaceutical Co Ltd Strategic Asset Allocation Index (2012–2022)
This chart shows how Nanjing Hicin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 58.7%, representing strategic assets of CN¥569.89 Million against net assets of CN¥970.16 Million CNY. For live market cap and overall valuation, see market cap of Nanjing Hicin Pharmaceutical Co Ltd.
Annual Strategic Asset Allocation Index for Nanjing Hicin Pharmaceutical Co Ltd (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 300584 net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 53.2% | CN¥505.53 Million | CN¥505.53 Million | CN¥- | CN¥950.57 Million | ▲ +14.1 pp |
| 2021 | 39.1% | CN¥370.75 Million | CN¥370.75 Million | CN¥- | CN¥948.48 Million | ▼ -6.7 pp |
| 2020 | 45.8% | CN¥310.81 Million | CN¥310.81 Million | CN¥- | CN¥678.97 Million | ▼ -2.2 pp |
| 2019 | 48.0% | CN¥313.84 Million | CN¥313.84 Million | CN¥- | CN¥653.98 Million | ▼ -30.2 pp |
| 2018 | 78.2% | CN¥454.14 Million | CN¥323.87 Million | CN¥130.28 Million | CN¥580.93 Million | ▲ +24.3 pp |
| 2017 | 53.9% | CN¥278.83 Million | CN¥278.03 Million | CN¥800.00K | CN¥517.68 Million | ▼ -27.1 pp |
| 2016 | 80.9% | CN¥223.49 Million | CN¥223.49 Million | CN¥- | CN¥276.11 Million | ▲ +5.4 pp |
| 2015 | 75.6% | CN¥177.63 Million | CN¥177.63 Million | CN¥- | CN¥235.08 Million | ▼ -0.3 pp |
| 2014 | 75.9% | CN¥151.93 Million | CN¥151.93 Million | CN¥- | CN¥200.15 Million | ▼ -3.9 pp |
| 2013 | 79.8% | CN¥132.47 Million | CN¥132.47 Million | CN¥- | CN¥165.93 Million | ▲ +23.8 pp |
| 2012 | 56.0% | CN¥74.33 Million | CN¥74.33 Million | CN¥- | CN¥132.65 Million | — |